Abstract
Measurements of serum enzymes are among the 20 most frequently ordered tests in clinical laboratories. Current participation reports for external quality assessment schemes (EQAS) show that the assays (Roche Diagnostics) used for our study are widely used in Germany and account for approximately 50% of EQAS participants for AST, ALT and GGT. For our study, these assays were implemented on only one platform (cobas® analyzer), and no other assays or manufacturers were used. AST and ALT assays included the addition of pyridoxal‐5‐phosphate, as required for standardization by the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC).
This article is protected by copyright. All rights reserved.
http://bit.ly/2R2fnGC
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου
Σημείωση: Μόνο ένα μέλος αυτού του ιστολογίου μπορεί να αναρτήσει σχόλιο.